Microsomal reductive glycosidase
- PMID: 6790
Microsomal reductive glycosidase
Abstract
Rat liver microsomes contain a phenobarbital inducible, NADPH dependent, reductive glycosidase capable of cleaving several anthracycline antibiotics, including adriamycin and daunorubicin, to deoxyaglycone products. The pH optimum for the reaction ranges from 7 to 7.4, and no metal requirements are noted. Molecular oxygen reversibly inhibits the microsomal enzyme greater than 95% at 20% oxygen partial pressure. Carbon monoxide, SKF 525A and sulfhydryl reagents are not inhibitory to the reaction, but the enzyme is sensitive to Cu++ and Zn++. Since the intact glycoside is necessary for conversion to the deoxyaglycone and a possible intermediate hydroxylated aglycone is not reduced to the deoxyaglycone, a concerted reaction mechanism is proposed. The reductive glycosidase activity is also present in rat brain, kidney and other tissues. Sensitivity of this enzyme to molecular oxygen suggests a possible regulatory role for the enzyme in vivo.
Similar articles
-
Metabolism of dihalomethanes to carbon monoxide. II. In vitro studies.Drug Metab Dispos. 1975 Mar-Apr;3(2):104-12. Drug Metab Dispos. 1975. PMID: 236156
-
Properties of microsomal enzyme systems that reduce N-hydroxyphentermine.Drug Metab Dispos. 1976 Sep-Oct;4(5):436-41. Drug Metab Dispos. 1976. PMID: 10142
-
Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.J Pharmacol Exp Ther. 1983 Sep;226(3):806-16. J Pharmacol Exp Ther. 1983. PMID: 6411900
-
Formation of reductive metabolite, 2-sulfamoylacetylphenol, from zonisamide in rat liver microsomes.Res Commun Chem Pathol Pharmacol. 1992 Jul;77(1):31-41. Res Commun Chem Pathol Pharmacol. 1992. PMID: 1439179
-
Metabolism of haloforms to carbon monoxide. I. In vitro studies.Drug Metab Dispos. 1977 Mar-Apr;5(2):198-204. Drug Metab Dispos. 1977. PMID: 15814
Cited by
-
Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbit.Cancer Chemother Pharmacol. 1988;22(4):294-8. doi: 10.1007/BF00254234. Cancer Chemother Pharmacol. 1988. PMID: 3168142
-
Mathematical model for adriamycin (doxorubicin) pharmacokinetics.Cancer Chemother Pharmacol. 1979;3(2):125-31. doi: 10.1007/BF00254984. Cancer Chemother Pharmacol. 1979. PMID: 509697
-
Hepatic metabolism of doxorubicin in mice and rats.Eur J Drug Metab Pharmacokinet. 1986 Apr-Jun;11(2):101-5. doi: 10.1007/BF03189834. Eur J Drug Metab Pharmacokinet. 1986. PMID: 3770010
-
Biotransformations of anthracyclinones in Streptomyces coeruleorubidus and Streptomyces galilaeus.Folia Microbiol (Praha). 1979;24(2):117-27. doi: 10.1007/BF02927295. Folia Microbiol (Praha). 1979. PMID: 456946
-
Adriamycin uptake and metabolism in organotypic culture of A549 human adenocarcinoma cells according to the exposure time.J Cancer Res Clin Oncol. 1990;116(6):633-8. doi: 10.1007/BF01637086. J Cancer Res Clin Oncol. 1990. PMID: 2254382 Free PMC article.